Palatin Technologies
PTN
#10101
Rang
€21.12 M
Capitalisation boursière
12,41 €
Prix de l'action
-1.74%
Changement (1 jour)
1,297.46%
Changement (1 an)

Palatin Technologies (PTN) - Dette totale

Dette totale au bilan au Septembre 2025 : 0.11 Million d'euros

Selon les derniers rapports financiers de Palatin Technologies, la dette totale de l'entreprise est de 0.11 Million d'euros. La dette totale d'une entreprise est la somme de toutes les dettes courantes et non courantes.

Palatin Technologies - Dette totale au bilan (de 1997 à 2025)

Dette totale par année

Année Dette totale Changement
2025-06-30€0.13 M-74.73%
2024-06-30€0.54 M-42.88%
2023-06-30€0.96 M-12.58%
2022-06-30€1.1 M4.26%
2021-06-30€1.05 M-6.27%
2020-06-30€1.12 M284.7%
2019-06-30€0.29 M-94.54%
2018-06-30€5.36 M-56.63%
2017-06-30€12.37 M-29.6%
2016-06-30€17.57 M98.75%
2015-06-30€8.84 M
2014-06-30N/A-100%
2013-06-30€0.01 M-54.1%
2012-06-30€0.03 M-37.34%
2011-06-30€0.05 M95.93%
2010-06-30€0.02 M-68.44%
2009-06-30€0.08 M-64.8%
2008-06-30€0.24 M-33.25%
2007-06-30€0.36 M46.65%
2006-06-30€0.24 M886.38%
2005-06-30€0.02 M-51.68%
2004-06-30€0.05 M-77.35%
2003-06-30€0.23 M
2001-06-30€0.03 M
1999-06-30€1.94 M156.09%
1998-06-30€0.75 M-50%
1997-06-30€1.51 M-44.71%
1996-06-30€2.74 M

Dette totale pour des entreprises similaires ou concurrentes

Entreprise Dette totale/th> Dette totale différencediff. Pays
Johnson & Johnson
JNJ
€38.63 Md 34,576,255.65%🇺🇸 USA
AstraZeneca
AZN
€27.52 Md 24,637,865.66%🇬🇧 UK
Neurocrine Biosciences
NBIX
€0.36 Md 323,352.58%🇺🇸 USA
MediciNova
MNOV
€0.15 M 36.47%🇺🇸 USA
Ligand Pharmaceuticals
LGND
€0.38 Md 340,413.87%🇺🇸 USA
Dicerna Pharmaceuticals
DRNA
N/AN/A🇺🇸 USA
ANI Pharmaceuticals
ANIP
€0.52 Md 468,249.37%🇺🇸 USA
GlycoMimetics
GLYC
N/AN/A🇺🇸 USA
Ardelyx
ARDX
€0.17 Md 156,651.43%🇺🇸 USA